This inventor holds 1 USPTO granted patent. Top assignee: Sinclair Pharmaceuticals Limited. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Marco Mastradonato: Innovator in Inflammation Treatment
Introduction
Marco Mastradonato is a notable inventor based in Milan, Italy. He has made significant contributions to the field of medical treatments, particularly focusing on inflammation-related conditions. His innovative approach combines advanced compounds to address various painful ailments affecting moist epithelial surfaces.
Latest Patents
Mastradonato holds a patent for "Compositions and methods for the treatment or prevention of inflammation." This invention involves compounds that contain hyaluronic acid and polyvinylpyrrolidone as active ingredients. The patent aims to provide effective treatment for inflammatory, ulcerative, and painful conditions such as mucositis, stomatitis, vestibulitis, aphthous ulcerations, and Behcet's syndrome. He has 1 patent to his name.
Career Highlights
Marco Mastradonato is associated with Sinclair Pharmaceuticals Limited, where he applies his expertise in developing innovative medical solutions. His work has been instrumental in advancing treatments that improve patient outcomes in inflammatory conditions.
Collaborations
Mastradonato collaborates with Gianluca Braguti, contributing to the development of effective therapeutic strategies. Their partnership enhances the research and innovation efforts within their field.
Conclusion
Marco Mastradonato is a dedicated inventor whose work in inflammation treatment showcases his commitment to improving healthcare. His innovative patent reflects his expertise and the potential impact of his contributions on patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile